Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens? Suarez EU, Boluda B, Lavilla E, Tormo M, et al. Ann Hematol 2024;103:2845-2851.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Suarez EU, Boluda B, Lavilla E, Tormo M, et al. Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens? Ann Hematol 2024;103:2845-2851.
PMID: 38884787